43798-015 : Sustiva 50 mg Oral Capsule


NDC: 43798-015
Labeler: Aesica Queenborough Limited
Product Type: Human Prescription Drug
Drug Name:  Sustiva
Dosage Form: Oral Capsule
Application #: NDA020972
Rev. Date: 


Appearance:


Markings: SUSTIVA;50
Shapes:  Capsule
Colors:  White / Yellow
Size (mm): 14
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 43798-015-01: 12 BOTTLE IN 1 CASE (43798‑015‑01) > 30 CAPSULE IN 1 BOTTLE

Active Ingredients:

  • Efavirenz

Dosage Strength:

  • 50 mg

Inactive Ingredients:

  • Sodium Starch Glycolate Type a Potato
  • Sodium Lauryl Sulfate
  • Lactose Monohydrate
  • Magnesium Stearate /

Pharmaceutical Classes:

  • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Non-Nucleoside Analog [Chemical/Ingredient]
  • Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
  • Cytochrome P450 3A Inducers [MoA]
  • Cytochrome P450 2B6 Inducers [MoA]
  • Cytochrome P450 2C9 Inhibitors [MoA]
  • Cytochrome P450 2C19 Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 43798-016 Sustiva 200 mg Oral Capsule by Aesica Queenborough Limited
  • 0056-0470 Sustiva 50 mg Oral Capsule by Bristol-myers Squibb Pharma Company
  • 0056-0474 Sustiva 200 mg Oral Capsule by Bristol-myers Squibb Pharma Company
  • 0056-0510 Sustiva 600 mg Oral Tablet by Bristol-myers Squibb Pharma Company
  • 24236-282 Sustiva 600 mg Oral Tablet, Film Coated by Remedyrepack Inc.
  • 54569-5374 Sustiva 600 mg Oral Tablet, Film Coated by A-s Medication Solutions
  • 54868-4668 Sustiva 600 mg Oral Tablet by Physicians Total Care, Inc.
  • 70518-0482 Sustiva 600 mg Oral Tablet, Film Coated by Remedyrepack Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 43798-015 QR Code

< Prev: 43773-1001Next: 43798-016 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.